CNBC Television
CNBC Television
@CNBCtelevision·3.4M subscribers·155K videos

Novo and Lilly are competing to win the GLP-1 pill market

Posted

June 8, 2026

Views

1,280

Likes

15

Comments

2

Engagement

1.33%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs.

CNBC's Angelica Peebles explains.

Guests & Subjects Covered

Novo NordiskEli LillyCNBC's Angelica Peebles

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Novo and Lilly are competing to win the GLP-1 pill market · CNBC Television · Sentinel